主要真菌毒素的酶解毒:目前的状况,挑战和未来的前景
Qiuhong Zhong1,2, Qinghua Wu3, Xiaoli Xu4
1College of Life Science, Yangtze University, Jingzhou, 434025, China.
Mycotoxin research
|September 24, 2025
概括
酶降解提供了一种安全有效的方法来中和食品中的有害真菌毒素. 本综述探讨了能将毒素 (如亚毒素和毒素) 转化为少毒物质的酶.
科学领域:
- 食品科学 食品科学 食品科学
- 生物技术是生物技术.
- 毒理学 毒理学 毒理学
背景情况:
- 毒素在全球范围内污染谷物,对人类和动物健康构成重大风险.
- 目前的排毒方法在有效性,选择性或环境影响方面存在局限性.
研究的目的:
- 为了提供对菌毒素降解酶的全面概述.
- 详细介绍主要真菌毒素的酶特性和降解途径.
- 突出酶降解作为一个有前途的排毒策略.
主要方法:
- 关于菌毒素降解酶的科学出版物的文献综述.
- 酶类的分析,包括过氧化酶,乳酶,雌激酶和氧降解酶.
- 对亚毒素 (AFs), ochratoxins (OTs),deoxynivalenol (DON),zearalenone (ZEN) 和fumonisins (FUMs) 的降解途径的检查.
主要成果:
- 多种类型的酶表现出降解各种真菌毒素的能力.
- 不同的酶途径有效地将菌毒素转化为少毒的化合物.
- 酶降解显示出高选择性和环境兼容性.
结论:
- 酶降解是一种高效,选择性和环保的方法来中和真菌毒素.
- 鉴定出来的酶为食品和料中菌毒素的彻底排毒提供了一个有前途的解决方案.
- 对这些酶的进一步研究可以提高食品安全,减少健康危害.
更多相关视频
08:21Isolation and Screening from Soil Biodiversity for Fungi Involved in the Degradation of Recalcitrant Materials
Published on: May 16, 2022
5.7K
09:44RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem
Published on: December 21, 2015
21.5K
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
773
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
773
Enhanced Elimination of Poison
833
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
833
Bioremediation
22.0K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
22.0K
Toxic Reactions: Overview
1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
